Matinas BioPharma (MTNB) Reports In-Line Q1 EPS

Matinas BioPharma (NYSE: MTNB) reported Q1 EPS of ($0.03), in-line with the analyst estimate of ($0.03).

For earnings history and earnings-related data on Matinas BioPharma (MTNB) click here.

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• Bimergen Energy Corporation (BESS) Reports Q2 EPS of $0.22
• BofA Securities Reiterates Buy Rating on Micron Technology (MU); Sees $230+ in EPS by FY30